| 1 |
Kuczmarski AV, Welti LM, Moreau KL, Wenner MM. ET-1 as a Sex-Specific Mechanism Impacting Age-Related Changes in Vascular Function. Front Aging 2021;2:727416. [PMID: 35822003 DOI: 10.3389/fragi.2021.727416] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 2 |
Jain A, Bozovicar K, Mehrotra V, Bratkovic T, Johnson MH, Jha I. Investigating the specificity of endothelin-traps as a potential therapeutic tool for endothelin-1 related disorders. World J Diabetes 2022; 13(6): 434-441 [DOI: 10.4239/wjd.v13.i6.434] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 3 |
Bippes CC, Kohler C, Garcia-Tirado E, Burri R, Frauenknecht T, Gerard MA, Salat M, Allenspach R, Agca C, Wu Z, Trost A, Bogner B, Meyer P, Scholl HPN, Reitsamer H, Flammer J, Neutzner A. Endosomal disentanglement of a transducible artificial transcription factor targeting endothelin receptor A. Mol Ther 2022;30:855-67. [PMID: 34547467 DOI: 10.1016/j.ymthe.2021.09.018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 4 |
Konieczka K, Flammer J. Treatment of Glaucoma Patients with Flammer Syndrome. J Clin Med 2021;10:4227. [PMID: 34575340 DOI: 10.3390/jcm10184227] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 5 |
Feng L, Wang S, Chen F, Zhang C, Wang Q, Zhao Y, Zhang Z. Hepatic Knockdown of Endothelin Type A Receptor (ETAR) Ameliorates Hepatic Insulin Resistance and Hyperglycemia Through Suppressing p66Shc-Mediated Mitochondrial Fragmentation in High-Fat Diet-Fed Mice. Diabetes Metab Syndr Obes 2021;14:963-81. [PMID: 33688230 DOI: 10.2147/DMSO.S299570] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 6 |
Lan Y, Yang X, Liang Y, Lei L, Li Y, Wang S. Vasomotor tone-associated factors and pregnancy outcomes of women who undergo in vitro fertilization. Growth Factors 2021;39:28-36. [PMID: 34969347 DOI: 10.1080/08977194.2021.2021899] [Reference Citation Analysis]
|
| 7 |
Jain A, Mehrotra V. ET-traps as a potential treatment for COVID-19. Medicine in Drug Discovery 2020;7:100054. [DOI: 10.1016/j.medidd.2020.100054] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 8 |
Jain A, Johnson MH. ET-traps offer a potential therapeutic tool for use in different autoimmune diseases. Drug Discov Today 2020;25:1142-5. [PMID: 32325125 DOI: 10.1016/j.drudis.2020.04.011] [Reference Citation Analysis]
|
| 9 |
Cahn A, Cernea S, Raz I. The SONAR study-is there a future for endothelin receptor antagonists in diabetic kidney disease? Ann Transl Med 2019;7:S330. [PMID: 32016048 DOI: 10.21037/atm.2019.09.117] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 10 |
Wernly B, Jung C. Trapping endothelin-1 to hunt down cardiovascular disease? Drug Discov Today 2019;24:2108-10. [PMID: 31654816 DOI: 10.1016/j.drudis.2019.10.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
|
